STZ-Induced Diabetes Model
logo

STZ-Induced Diabetes Model

Streptozotocin (STZ), a nitroso-containing antibiotic that specifically destroys pancreatic β-cells and enhances their oxidative invasion by inducing nitric oxide (NO) synthesis, is widely used in the establishment of experimental models of type 1 diabetes mellitus (T1DM).

Welcome to download our promotional materials on the STZ-Induced Diabetes Model! This detailed information will provide you with a comprehensive understanding of the Streptozotocin (STZ)-induced diabetes model, helping you achieve breakthroughs in the field of diabetes research.

This promotional material will provide you with a detailed presentation of:

  • Deep insights: This poster details not only the theoretical foundations of the STZ-induced diabetes model but also demonstrates its establishment and evaluation through practical case studies, enabling comprehensive mastery of this critical experimental methodology.
  • Experimental guidance: Step-by-step protocols and validated data outputs provide reliable references for your diabetes research, streamlining your investigative workflow.
  • Research enablement: Successfully established STZ-induced diabetic models deliver robust experimental platforms to accelerate discovery and drive successful outcomes in diabetes research programs.

Download now to access comprehensive details on the STZ-Induced Diabetes Model and empower your diabetes research with robust scientific support! For further inquiries, please contact our dedicated customer service team.

logo

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top